T0	Disease 106 128	Ehlersâ€“Danlos syndrome
#1	AnnotatorNotes T0	DOID:13359
T10	Disease 830 843	breast cancer
#2	AnnotatorNotes T10	DOID:1612
T12	Disease 1007 1020	breast cancer
T14	Disease 1074 1079	tumor
#4	AnnotatorNotes T14	DOID:162
T16	Disease 1133 1157	hepatocellular carcinoma
#6	AnnotatorNotes T16	DOID:684
T19	Disease 1280 1286	cancer
#7	AnnotatorNotes T19	DOID:14566|DOID:162
T2	Disease 384 390	cancer
#8	AnnotatorNotes T2	DOID:162
T20	Disease 1385 1406	hepatocellular cancer
#9	AnnotatorNotes T20	DOID:5015
T21	Disease 1424 1439	PLOD2-deficient
#10	AnnotatorNotes T21	not found
T23	Disease 1553 1570	colorectal cancer
#11	AnnotatorNotes T23	DOID:9256
T24	Chemical 1656 1661	lysyl
T26	Disease 1807 1810	RCC
#14	AnnotatorNotes T26	DOID:4450
T27	Disease 1894 1909	kidney fibrosis
#15	AnnotatorNotes T27	DOID:0050855
T4	Disease 568 578	carcinomas
#16	AnnotatorNotes T4	DOID:305
T6	Disease 644 678	esophageal squamous-cell carcinoma
#17	AnnotatorNotes T6	DOID:7051
T1	Gene-Protein 70 75	PLOD1
#12	AnnotatorNotes T1	HGNC:9081
T3	Gene-Protein 616 621	PLOD1
T5	Gene-Protein 780 785	PLOD2
T7	Gene-Protein 985 990	PLOD2
T9	Gene-Protein 1159 1164	PLOD2
T11	Gene-Protein 1607 1612	PLOD2
T13	Gene-Protein 1482 1487	PLOD2
T17	Gene-Protein 1424 1429	PLOD2
T18	Gene-Protein 626 631	PLOD2
#19	AnnotatorNotes T18	HGNC:9082
T22	Gene-Protein 1233 1238	PLOD3
#20	AnnotatorNotes T22	HGNC:9083
T28	Biomarker 30 80	More than 30 genetic alterations in the PLOD1 gene
R1	Risk-Factor Arg1:T28 Arg2:T0	
T29	Biomarker 278 324	Elevated collagen deposition and cross-linking
R2	Prognostic-Poor Arg1:T29 Arg2:T2	
T30	GeneFamily 534 539	PLODs
#21	AnnotatorNotes T30	family:2023
T31	Biomarker 496 539	Significantly increased expression of PLODs
R3	Association Arg1:T31 Arg2:T4	
T32	Biomarker 597 631	high expression of PLOD1 and PLOD2
T33	Biomarker 1482 1549	PLOD2 and PLOD3 were among 54 glycoproteins found to be upregulated
R4	Association Arg1:T32 Arg2:T6	
R5	Association Arg1:T33 Arg2:T23	
T8	Biomarker 780 826	PLOD2 expression was significantly upregulated
R6	Prognostic-Poor Arg1:T8 Arg2:T10	
T25	RNA-Noncoding 1758 1765	miR-26a
#3	AnnotatorNotes T25	family:1739
T34	Gene-Protein 1656 1679	lysyl oxidase homolog-2
#13	AnnotatorNotes T34	HGNC:6666
T35	RNA-Noncoding 1770 1777	miR-26b
#18	AnnotatorNotes T35	HGNC:31612
T36	Biomarker 1233 1271	PLOD3 was found to be highly expressed
R7	Association Arg1:T36 Arg2:T19	
T38	GeneFamily 1039 1047	collagen
T39	GeneFamily 1625 1633	collagen
T15	Biomarker 1031 1058	reduced collagen deposition
T40	Biomarker 1159 1175	PLOD2 expression
T41	Gene-Protein 1492 1497	PLOD3
T42	GeneFamily 287 295	collagen
#5	AnnotatorNotes T42	family:490
R8	Association Arg1:T40 Arg2:T16	
R9	Association Arg1:T36 Arg2:T16	
T43	Biomarker 1607 1612	PLOD2
T44	Biomarker 1656 1679	lysyl oxidase homolog-2
T45	Collection 1607 1679	PLOD2 and another collagen cross-linking enzyme, lysyl oxidase homolog-2
R10	Association Arg1:T45 Arg2:T26	
#22	AnnotatorNotes T43	C479138
T37	Drug 972 1001	knockdown of PLOD2 expression
#23	AnnotatorNotes T37	not found
T46	Collection 1007 1079	breast cancer cell line reduced collagen deposition in the primary tumor
R11	Response Arg1:T37 Arg2:T46	
